139 related articles for article (PubMed ID: 2165247)
1. [Infectious complications of the treatment of acute lymphoblastic leukemia in children].
Rubie H; Assouline C; Prere MF; Dutour A; Lemozy J; Mouls JL; Gayet-Mengelle C; Robert A
Pediatrie; 1990; 45(5):333-8. PubMed ID: 2165247
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.
Afzal S; Ethier MC; Dupuis LL; Tang L; Punnett AS; Richardson SE; Allen U; Abla O; Sung L
Pediatr Infect Dis J; 2009 Dec; 28(12):1064-8. PubMed ID: 19773675
[TBL] [Abstract][Full Text] [Related]
3. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.
Meir HM; Balawi IA; Meer HM; Nayel H; Al-Mobarak MF
Saudi Med J; 2001 May; 22(5):423-7. PubMed ID: 11376385
[TBL] [Abstract][Full Text] [Related]
4. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
5. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
[TBL] [Abstract][Full Text] [Related]
6. [Report on induction efficacy of protocol ALL-2005 and middle term follow-up of 158 cases of childhood acute lymphoblastic leukemia].
Tang JY; Gu LJ; Xue HL; Chen J; Pan C; Wu WT; Shen SH; Dong L; Zhou M; Ye QD; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):289-93. PubMed ID: 19799121
[TBL] [Abstract][Full Text] [Related]
7. [Trimethoprim-sulfamethoxazole as antibacterial prophylaxis during induction therapy of children with acute lymphatic leukemia].
Agger KE; Schrøder H; Rosthøj S; Carlsen NT; Schmiegelow K
Ugeskr Laeger; 2002 Jan; 164(4):488-92. PubMed ID: 11838420
[TBL] [Abstract][Full Text] [Related]
8. Anti-Erwinia asparaginase antibodies during treatment of childhood acute lymphoblastic leukemia and their relationship to outcome: a case-control study.
Klug Albertsen B; Schmiegelow K; Schrøder H; Carlsen NT; Rosthøj S; Avramis VI; Jakobsen P
Cancer Chemother Pharmacol; 2002 Aug; 50(2):117-20. PubMed ID: 12172975
[TBL] [Abstract][Full Text] [Related]
9. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of childhood acute leukemia: a long-term follow-up study of CCLSG-high risk ALL 811 (phase III study). Children's Cancer & Leukemia Study Group].
Mimaya J; Fujimoto T; Takeda T; Yanai M; Yatabe M; Utumi J; Hiyosi Y; Koizumi S; Tanaka K; Yaoi K
Rinsho Ketsueki; 1988 Sep; 29(9):1357-64. PubMed ID: 3063852
[No Abstract] [Full Text] [Related]
12. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
14. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
[TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.
Kudva GC; Chandy M; Raghupathy P; Dennison D; Srivastava A; Bhushan V; Singh R
Indian J Cancer; 1994 Jun; 31(2):78-85. PubMed ID: 7927453
[TBL] [Abstract][Full Text] [Related]
16. [Bacteremia in children with acute lymphoblastic leukemia].
Schrøder H; Lassen BT; Andersen ST; Hansen US; Møller JK
Ugeskr Laeger; 1998 Sep; 160(38):5487-90. PubMed ID: 9763921
[TBL] [Abstract][Full Text] [Related]
17. [Acute lymphoblastic leukemia in children. Results of a protocol including bone marrow transplantation during the first remission in high-risk forms for relapse].
Michel G; Maraninchi D; Thuret I; Fay C; Guitard AM; Mozziconacci MJ; Novakovitch G; Capodano AM; Tubiana N; Perrimond H
Arch Fr Pediatr; 1990 Mar; 47(3):163-8. PubMed ID: 2188630
[TBL] [Abstract][Full Text] [Related]
18. [High risk febrile neutropenia in acute leukemia. The experience of a public hospital. National Program of Antineoplastic Drugs in Adult, Hospital del Salvador, 1991-2001].
Puga B; Puga I; Cabrera ME; Undurraga MS; Guerra C; Urrejola G; Toro P
Rev Med Chil; 2003 Sep; 131(9):1023-30. PubMed ID: 14635589
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia.
Poulsen A; Demeny AK; Bang Plum C; Gjerum Nielsen K; Schmiegelow K
Med Pediatr Oncol; 2001 Jul; 37(1):20-3. PubMed ID: 11466718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
